Skip to main content
Fig. 2 | Molecular Neurodegeneration

Fig. 2

From: Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging

Fig. 2

Lrrk2-deficiency disturbs genomic stability and epigenetic modification during aging. a The expression levels of γH2A.X and H3K9me2 were detected by western blot analysis from the striatal samples of Lrrk2+/+ and Lrrk2−/− mice at 2, 12 and 24 months of age. b, c The ratios of γH2A.X (b) and H3K9me2 (c) against H2A and H3, respectively. N = 3 per genotype and per time point. Data were presented as mean ± SEM. 2way ANOVA analysis with Sidak’s multiple comparisons test of γH2A.X, ****p < 0.0001 (Lrrk2+/+ vs. Lrrk2−/− at 12 months of age), ****p < 0.0001 (Lrrk2+/+ vs. Lrrk2−/− at 24 months of age). 2way ANOVA analysis with Sidak’s multiple comparisons test of H3K9me2 expressions, ****p < 0.0001. d Co-staining of γH2A.X and CTIP2 in the striatal sections of 2-, 12-, and 24-month-old Lrrk2+/+ and Lrrk2−/− mice. Scale bar, 5 μm. e The ratios of SPNs with 10 or more γH2A.X-positive foci in the nuclei. N = 3 or 4 mice per genotype, 400 neurons per animal. Data were presented as mean ± SEM. Unpaired t-test, *p = 0.0126 (12 M, +/+ vs. −/−), *p = 0.0132 (24 M, +/+ vs. −/−)

Back to article page